尽管分析师乐观地预测 56.36 美元的目标价，但 Tempus AI 面临更多的空头股数。 Tempus AI faces increased short interest despite analysts' optimistic $56.36 target price.

Tempus AI是一家使用AI进行精密医学的保健技术公司,12月的短期利息上升了42.2%,现在出售的股票不足17.8%。 Tempus AI, a healthcare tech company using AI for precision medicine, saw short interest rise by 42.2% in December, with 17.8% of shares now sold short. 分析师仍持乐观态度,给“机动购买”评级,目标价格为56.36美元。 Analysts remain optimistic, giving a "Moderate Buy" rating and a $56.36 target price. 最近,内部投资者出售了价值3 590万美元的股票,机构投资者拥有24.22%的股票。 Insiders have recently sold $35.9 million worth of shares, and institutional investors own 24.22% of the stock.